Minerva Neurosciences Inc (NAS:NERV)
$ 2.94 0.39 (15.29%) Market Cap: 20.56 Mil Enterprise Value: -16.36 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 37/100

Minerva Neurosciences, Inc. - Special Call Transcript

Dec 18, 2019 / 10:00PM GMT
Release Date Price: $55.12 (-1.01%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Minerva Neurosciences December 18, 2019 Conference Call. (Operator Instructions)

I would now like to hand the conference to your speaker today, William Boni, Vice President of Investor Relations. Please go ahead, sir.

William B. Boni
Minerva Neurosciences, Inc. - VP of IR & Corporate Communications

Good evening, everyone. A press release announcing top line results from the Phase IIb trial of MIN-117 became available at 4:05 p.m. Eastern Time today and can be found on the Investors section of our website.

Joining me on the call today from Minerva are Dr. Rémy Luthringer, Executive Chairman and Chief Executive Officer; Mr. Geoff Race, Executive Vice President, Chief Financial Officer and Chief Business Officer; and Mr. Rick Russell, President. Following our prepared remarks, we will open the call for Q&A.

Before we begin, I would like to remind you that today's discussion will include statements about the company's future expectations, plans and prospects

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot